Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amyris Inc (AMRS)

Amyris Inc (AMRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 657,927
  • Shares Outstanding, K 163,055
  • Annual Sales, $ 152,560 K
  • Annual Income, $ -242,770 K
  • 60-Month Beta 0.51
  • Price/Sales 5.28
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.12
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.12
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +76.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.75 +7.60%
on 08/06/20
5.05 -20.10%
on 08/05/20
-0.73 (-15.32%)
since 07/06/20
3-Month
2.26 +78.54%
on 05/08/20
6.07 -33.53%
on 06/01/20
+1.69 (+72.44%)
since 05/06/20
52-Week
1.40 +188.21%
on 03/16/20
6.07 -33.53%
on 06/01/20
+1.20 (+42.58%)
since 08/06/19

Most Recent Stories

More News
Amyris, Inc. Reports Second Quarter 2020 Results

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients,...

AMRS : 4.03 (-18.32%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Amyris, Inc.

Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Amyris, Inc. ("Amyris" or the "Company")...

AMRS : 4.03 (-18.32%)
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS

, /PRNewswire/ -- , founder and managing partner at , a national securities firm headquartered at the in , is investigating Amyris, Inc. ("Amyris" or the "Company") (Nasdaq: AMRS) relating to the...

AMRS : 4.03 (-18.32%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.

, /PRNewswire/ --

AMRS : 4.03 (-18.32%)
Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets and IDRI (Infectious Disease Research Institute) today announce the signing...

AMRS : 4.03 (-18.32%)
Amyris To Host Second Quarter 2020 Financial Results Conference Call On August 6

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients,...

AMRS : 4.03 (-18.32%)
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for potential...

AMRS : 4.03 (-18.32%)
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for potential...

AMRS : 4.03 (-18.32%)
Amyris Launches Plant-derived Sustainable Silica for Clean Beauty Applications

, /PRNewswire/ -- , an Amyris, Inc. (Nasdaq: AMRS) joint venture, the leading supplier of high performance, clean beauty ingredients is commercializing a plant-derived silica made from sugarcane ashes....

AMRS : 4.03 (-18.32%)
Cannabis Sales Surge During Lock Down

, /PRNewswire/ --  As the pandemic wreaked havoc on the U.S. and global economies, cannabis sales rocketed higher across multiple markets in North America. California nearly 160% compared to the same...

VFF : 6.10 (-0.33%)
HEXO : 0.6972 (-0.75%)
AMRS : 4.03 (-18.32%)
TLRY : 7.76 (-4.32%)
NUGS : 0.0790 (-3.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AMRS with:

Business Summary

Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged...

See More

Key Turning Points

2nd Resistance Point 4.71
1st Resistance Point 4.37
Last Price 4.03
1st Support Level 3.72
2nd Support Level 3.41

See More

52-Week High 6.07
Fibonacci 61.8% 4.29
Last Price 4.03
Fibonacci 50% 3.74
Fibonacci 38.2% 3.18
52-Week Low 1.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar